Health3 weeks ago
New Study Highlights Durvalumab’s Potential in Small Cell Lung Cancer Treatment
A recent clinical trial has indicated that the immune checkpoint inhibitor durvalumab could provide innovative treatment options for patients diagnosed with small cell lung cancer (SCLC)....
